- 米国企業
- PROCEPT BioRobotics Corp
PROCEPT BioRobotics CorpPRCT
| 2021年 12月31日 | 2022年 12月31日 | 2023年 12月31日 |
---|
Net loss | -60 | -87 | -106 |
---|
Depreciation and amortization | 3 | 3 | - |
---|
Depreciation and amortization | - | - | 4 |
---|
Stock-based compensation expense | 4 | 10 | 19 |
---|
Fair Value Adjustment of Warrants and Gain (Loss) on Derivative Instruments, Net, Pretax | -0 | 0 | 0 |
---|
Non-cash lease adjustment | 0 | -1 | -0 |
---|
Inventory write-down | 1 | 0 | 1 |
---|
Loss on loan extinguishment | - | -3 | - |
---|
Accounts receivable, net | 3 | 11 | 33 |
---|
Inventory | 6 | 15 | 10 |
---|
Prepaid expenses and other current assets | 3 | 2 | -1 |
---|
Other assets | - | 0 | 1 |
---|
Accounts payable | 1 | 4 | 6 |
---|
Accrued compensation | 2 | 7 | 3 |
---|
Accrued interest expense | 1 | 1 | 0 |
---|
Deferred revenue | 1 | 2 | 3 |
---|
Operating lease liabilities | - | 0 | 5 |
---|
Other liabilities | 2 | 3 | -1 |
---|
Net cash used in operating activities | -57 | -80 | -108 |
---|
Purchases of property and equipment | 1 | 3 | 25 |
---|
Net cash used in investing activities | -1 | -3 | -25 |
---|
Proceeds from Issuance of Common Stock | - | 2 | 162 |
---|
Proceeds from Repayment of Loans by Employee Stock Ownership Plans | - | - | 4 |
---|
Proceeds from Stock Options Exercised | 4 | 4 | 2 |
---|
Proceeds from Issuance Initial Public Offering | 172 | - | - |
---|
Proceeds from Debt, Net of Issuance Costs | - | 51 | - |
---|
Proceeds from Issuance of Common Stock | - | 2 | 162 |
---|
Proceeds from Warrant Exercises | 1 | - | - |
---|
Proceeds from Issuance of Redeemable Convertible Preferred Stock, Net of Issuance Costs | 85 | - | - |
---|
Payment of principal on long-term debt | - | 50 | - |
---|
Proceeds from Debt, Net of Issuance Costs | - | 51 | - |
---|
Payment of final payment fee | - | 3 | - |
---|
Payment of principal on long-term debt | - | 50 | - |
---|
Payment of prepayment fee | - | 1 | - |
---|
Payment of final payment fee | - | 3 | - |
---|
Net cash provided by financing activities | 262 | 4 | 168 |
---|
Payment of prepayment fee | - | 1 | - |
---|
Net cash provided by financing activities | 262 | 4 | 168 |
---|
Net increase (decrease) in cash, cash equivalents and restricted cash | 204 | -79 | 35 |
---|
Interest paid | 5 | 4 | 4 |
---|
Transfer From Inventory to Property and Equipment, Net | -1 | 0 | 0 |
---|
Capital Expenditures Incurred but Not yet Paid | 0 | 4 | 2 |
---|
Conversion of Stock, Amount Converted | 330 | - | - |
---|
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | - | 23 | - |
---|
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | - | 23 | - |
---|
Conversion of Stock, Amount Converted | 330 | - | - |
---|